DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...

Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...

There is a considerable clinical need for alternatives to the autologous vein and artery tissues used for vascular reconstructive surgeries such as CABG, lower limb bypass, arteriovenous shunts ...

Humacyte ( (HUMA) ) has released its Q3 earnings. Here is a breakdown of the information Humacyte presented to its investors. Humacyte, Inc., a ...

where the tissue was wired to dual-grip flexible electrodes. Assessments at 60 and 120 days were encouraging, showing normal vascular structures, active neuronal synapse expression, and no abnormal ...

White matter is the tissue that forms connections between brain cells and ... “seeing your doctor at least every year or ...

UPMC Heart and Vascular Institute in central Pennsylvania has treated its first patient with a new therapy.

Diabetes-related amputations represent one of the most severe complications of the disease, affecting thousands of patients ...